ProfileGDS4718 / 202614_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 95% 94% 93% 94% 95% 96% 96% 94% 94% 95% 96% 92% 95% 96% 96% 96% 96% 95% 97% 93% 95% 95% 95% 95% 94% 95% 95% 93% 94% 96% 95% 96% 93% 94% 94% 95% 95% 94% 93% 94% 95% 95% 95% 94% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]10.24395
GSM549102patient 115, normal, homogenized [OPG study]9.9444794
GSM549104patient 119, normal, homogenized [OPG study]9.8337793
GSM549108patient 138, normal, homogenized [OPG study]10.013694
GSM549119patient 077, normal, homogenized [OPG study]10.265595
GSM549133patient 032, cancer, homogenized [OPG study]10.501496
GSM549139patient 042, cancer, homogenized [OPG study]10.393296
GSM549099patient 107, normal, homogenized [OPG study]9.9777994
GSM549109patient 139, normal, homogenized [OPG study]9.9200394
GSM549110patient 046, normal, homogenized [OPG study]10.373295
GSM549114patient 063, normal, homogenized [OPG study]10.638596
GSM549122patient 082, normal, homogenized [OPG study]9.6802192
GSM549134patient 033, cancer, homogenized [OPG study]10.326395
GSM549136patient 036, cancer, homogenized [OPG study]10.377996
GSM549140patient 044, cancer, homogenized [OPG study]10.391296
GSM549111patient 047, normal, homogenized [OPG study]10.679896
GSM549113patient 057, normal, homogenized [OPG study]10.744796
GSM549132patient 031, cancer, homogenized [OPG study]10.220695
GSM549137patient 038, cancer, homogenized [OPG study]10.689497
GSM549142patient 047, cancer, homogenized [OPG study]9.2446693
GSM549100patient 110, normal, homogenized [OPG study]10.144395
GSM549107patient 135, normal, homogenized [OPG study]10.236395
GSM549115patient 068, normal, homogenized [OPG study]10.543795
GSM549116patient 072, normal, homogenized [OPG study]10.295395
GSM549120patient 078, normal, homogenized [OPG study]10.110394
GSM549131patient 030, cancer, homogenized [OPG study]10.288695
GSM549118patient 074, normal, homogenized [OPG study]10.279395
GSM549129patient 027, cancer, homogenized [OPG study]9.6072893
GSM549123patient 088, normal, homogenized [OPG study]10.124294
GSM549124patient 006, cancer, homogenized [OPG study]10.366596
GSM549126patient 015, cancer, homogenized [OPG study]10.104995
GSM549128patient 025, cancer, homogenized [OPG study]10.424896
GSM549103patient 117, normal, homogenized [OPG study]9.664193
GSM549117patient 073, normal, homogenized [OPG study]10.3294
GSM549138patient 041, cancer, homogenized [OPG study]9.9802294
GSM549141patient 045, cancer, homogenized [OPG study]10.364495
GSM549130patient 028, cancer, homogenized [OPG study]10.19195
GSM549101patient 111, normal, homogenized [OPG study]9.8996394
GSM549105patient 128, normal, homogenized [OPG study]9.7882793
GSM549106patient 134, normal, homogenized [OPG study]10.092194
GSM549112patient 048, normal, homogenized [OPG study]10.505895
GSM549125patient 011, cancer, homogenized [OPG study]10.158295
GSM549127patient 024, cancer, homogenized [OPG study]10.032695
GSM549135patient 035, cancer, homogenized [OPG study]10.00794